Billam PLC
29 September 2000
The directors of Billam Plc have formed a new subsidiary called Global Life
Sciences Limited. They stated that this is in order to take advantage of
significant quality deal flow that they are currently receiving from companies
trading in the biotechnology and life science sectors.
It is proposed that Global Life Sciences will be listed on the Alternative
Investment Market (AIM) during November 2000. The Board of Billam Plc are
mindful that private investors in particular do not always have the chance to
participate in New Issues and will ensure that all shareholders in Billam Plc
have an opportunity to participate in this subscription offer.
Details of the proposed offer for subscription available to Billam Plc
shareholders, for new shares in Global Life Sciences will be made available to
qualifying shareholders as at 18 October 2000 by 26 October 2000.
28 September 2000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.